A new evidence-based guideline from the College of American Pathologists (CAP) aims to standardize amyloidosis diagnostics, from optimized Congo red protocols to more reliable fibril typing. CAP guideline panel members explain what prompted the update, where traditional methods fall short, and how techniques such as LC-MS/MS – and potentially infrared spectroscopy – may shape the future of amyloid typing.
For the full article click here: Mass Spectrometry Takes on Amyloid